bromodeoxyuridine has been researched along with Graft Occlusion, Vascular in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruggeman, CA; Grauls, GE; Kloppenburg, GT; Stassen, FR | 1 |
| Braune, M; Glasnov, TN; Groschner, K; Hoefler, G; Kappe, CO; Koenig, S; Maechler, H; Schernthaner, M; Wittchow, E | 1 |
| Cheung, AK; Kim, SJ; Leypoldt, JK; Masaki, T; Mohammad, SF; Rowley, R | 1 |
| Bell, PR; Jones, L; London, NJ; Porter, KE; Varty, K | 1 |
| Belkin, M; Conte, MS; Dell'Acqua, G; Donaldson, MC; Dzau, VJ; Ehsan, A; Mann, MJ; Orav, EJ; Polak, JF; Whittemore, AD | 1 |
| Braun-Dullaeus, R; Dell'Acqua, G; Dzau, VJ; Ehsan, A; Mann, MJ; Tamura, K | 1 |
1 trial(s) available for bromodeoxyuridine and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Blood Vessel Prosthesis Implantation; Bromodeoxyuridine; Carrier Proteins; Cell Cycle Proteins; DNA-Binding Proteins; Double-Blind Method; E2F Transcription Factors; Female; Genetic Therapy; Graft Occlusion, Vascular; Graft Survival; Humans; Life Tables; Male; Middle Aged; Oligonucleotides; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-myc; Retinoblastoma-Binding Protein 1; Statistics, Nonparametric; Transcription Factor DP1; Transcription Factors; Transfection | 1999 |
5 other study(ies) available for bromodeoxyuridine and Graft Occlusion, Vascular
| Article | Year |
|---|---|
Adenoviral activin A expression prevents vein graft intimal hyperplasia in a rat model.
Topics: Abdominal Muscles; Actins; Activins; Adenoviridae; Animals; Bromodeoxyuridine; Cell Proliferation; Constriction, Pathologic; Femoral Artery; Genetic Therapy; Genetic Vectors; Graft Occlusion, Vascular; Humans; Hyperplasia; Inhibin-beta Subunits; Male; Models, Animal; Muscle, Smooth, Vascular; Rats; Rats, Inbred Lew; Tunica Intima; Vascular Surgical Procedures; Veins | 2009 |
A TRPC3 blocker, ethyl-1-(4-(2,3,3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate (Pyr3), prevents stent-induced arterial remodeling.
Topics: Antimetabolites; Arteries; Blotting, Western; Bromodeoxyuridine; Calcium Signaling; Cell Proliferation; Cells, Cultured; Coronary Vessels; Graft Occlusion, Vascular; Humans; Hyperplasia; Immunohistochemistry; Isoenzymes; Myocytes, Smooth Muscle; Neointima; Organ Culture Techniques; Pyrazoles; Real-Time Polymerase Chain Reaction; RNA; Stents; Tissue Fixation; TRPC Cation Channels | 2013 |
Different responses by cultured aortic and venous smooth muscle cells to gamma radiation.
Topics: Antimetabolites; Aorta; Bromodeoxyuridine; Cell Count; Cell Division; Cells, Cultured; Coloring Agents; Gamma Rays; Graft Occlusion, Vascular; Humans; Muscle, Smooth, Vascular; Saphenous Vein; Tetrazolium Salts; Thiazoles; Thymidine; Tritium | 2005 |
Human saphenous vein organ culture: a useful model of intimal hyperplasia?
Topics: Bromodeoxyuridine; Cell Division; Graft Occlusion, Vascular; Humans; Hyperplasia; Muscle, Smooth, Vascular; Organ Culture Techniques; Saphenous Vein; Tunica Intima | 1996 |
Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease.
Topics: Animals; Bromodeoxyuridine; Carotid Arteries; Cell Count; Cell Cycle; Cell Cycle Proteins; Cell Division; Cells, Cultured; Disease Models, Animal; DNA-Binding Proteins; E2F Transcription Factors; Endothelium, Vascular; Genetic Therapy; Graft Occlusion, Vascular; Immunohistochemistry; Jugular Veins; Muscle, Smooth, Vascular; Oligonucleotides; Proliferating Cell Nuclear Antigen; Rabbits; Transcription Factors; Transfection; Treatment Outcome; Wound Healing | 2002 |